CC BY-NC-ND 4.0 · Journal of Digestive Endoscopy 2022; 13(01): 036-043
DOI: 10.1055/s-0041-1741465
Review Article

Are we Missing Barrett's Esophagus in Our Busy Endoscopy Practice? Improving Detection

Amit Kumar Dutta
1   Department of Gastrointestinal Sciences, Christian Medical College and Hospital, Vellore, Tamil Nadu, India
› Author Affiliations
Funding None.

Abstract

Barrett's esophagus (BE) denotes the replacement of stratified squamous epithelium of esophagus by columnar epithelium. It is associated with a significantly increased risk of esophageal adenocarcinoma and hence patients with BE are advised endoscopic surveillance for early detection of dysplastic and neoplastic lesions. Esophageal cancer is the sixth most common cancer in terms of incidence and mortality in India. Around 15 to 25% of esophageal cancers are adenocarcinoma. BE is likely to be an important precursor of esophageal adenocarcinoma and we may be missing patients with BE in our busy endoscopy practice. The detection of BE may be improved by identifying high-risk groups, performing thorough endoscopic examination, and applying newer imaging techniques. The high-risk group includes patients with chronic gastroesophageal reflux disease, obesity, smoking, etc. During endoscopic examination, a careful assessment of the gastroesophageal junction and identification of important landmarks such as gastroesophageal junction and Z line are essential to detect BE. Management of BE depends on the detection of dysplasia and for this four quadrant mucosal biopsy is recommended every 1 to 2 cm. However, random biopsy samples only a small area of mucosa and advanced technologies for real-time detection of dysplasia and neoplasia may overcome this limitation. In this review, we discuss the current scenario of BE in India and ways to improve the detection of BE including dysplastic lesions.



Publication History

Article published online:
11 February 2022

© 2022. Society of Gastrointestinal Endoscopy of India. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Peters Y, Al-Kaabi A, Shaheen NJ. et al. Barrett oesophagus. Nat Rev Dis Primers 2019; 5 (01) 35
  • 2 Marques de Sá I, Pereira AD, Sharma P, Dinis-Ribeiro M. Systematic review of the published guidelines on Barrett's esophagus: should we stress the consensus or the differences?. Dis Esophagus 2020; doaa115
  • 3 Bhatia SJ, Makharia GK, Abraham P. et al. Indian consensus on gastroesophageal reflux disease in adults: a position statement of the Indian Society of Gastroenterology. Indian J Gastroenterol 2019; 38 (05) 411-440
  • 4 Cerrone SA, Trindade AJ. Advanced imaging in surveillance of Barrett's esophagus: is the juice worth the squeeze?. World J Gastroenterol 2019; 25 (25) 3108-3115
  • 5 Krishnamurthy A, Behuria SS. Demographic trends in carcinoma esophagus from India along with a brief comparative review of global trends. South Asian J Cancer 2020; 9 (03) 163-167
  • 6 Qumseya BJ, Bukannan A, Gendy S. et al. Systematic review and meta-analysis of prevalence and risk factors for Barrett's esophagus. Gastrointest Endosc 2019; 90 (05) 707-717.e1
  • 7 Runge TM, Abrams JA, Shaheen NJ. Epidemiology of Barrett's esophagus and esophageal adenocarcinoma. Gastroenterol Clin North Am 2015; 44 (02) 203-231
  • 8 Maes S, Sharma P, Bisschops R. Review: surveillance of patients with Barrett oesophagus. Best Pract Res Clin Gastroenterol 2016; 30 (06) 901-912
  • 9 Rajendra S, Kutty K, Karim N. Ethnic differences in the prevalence of endoscopic esophagitis and Barrett's esophagus: the long and short of it all. Dig Dis Sci 2004; 49 (02) 237-242
  • 10 Mathew P, Joshi AS, Shukla A, Bhatia SJ. Risk factors for Barrett's esophagus in Indian patients with gastroesophageal reflux disease. J Gastroenterol Hepatol 2011; 26 (07) 1151-1156
  • 11 Punia RS, Arya S, Mohan H, Duseja A, Bal A. Spectrum of clinico-pathological changes in Barrett oesophagus. J Assoc Physicians India 2006; 54: 187-189
  • 12 Amarapurkar AD, Vora IM, Dhawan PS. Barrett's esophagus. Indian J Pathol Microbiol 1998; 41 (04) 431-435
  • 13 Wani IR, Showkat HI, Bhargav DK, Samer M. Prevalence and risk factors for Barrett's esophagus in patients with GERD in Northern India; do methylene blue-directed biopsies improve detection of Barrett's esophagus compared the conventional method?. Middle East J Dig Dis 2014; 6 (04) 228-236
  • 14 Eusebi LH, Cirota GG, Zagari RM, Ford AC. Global prevalence of Barrett's oesophagus and oesophageal cancer in individuals with gastro-oesophageal reflux: a systematic review and meta-analysis. Gut 2021; 70 (03) 456-463
  • 15 Chowdhury SD, George G, Ramakrishna K. et al. Prevalence and factors associated with gastroesophageal reflux disease in southern India: a community-based study. Indian J Gastroenterol 2019; 38 (01) 77-82
  • 16 Bhatia SJ, Reddy DN, Ghoshal UC. et al. Epidemiology and symptom profile of gastroesophageal reflux in the Indian population: report of the Indian Society of Gastroenterology Task Force. Indian J Gastroenterol 2011; 30 (03) 118-127
  • 17 Rai S, Kulkarni A, Ghoshal UC. Prevalence and risk factors for gastroesophageal reflux disease in the Indian population: a meta-analysis and meta-regression study. Indian J Gastroenterol 2021; 40 (02) 209-219
  • 18 Corley DA, Kubo A, Levin TR. et al. Race, ethnicity, sex and temporal differences in Barrett's oesophagus diagnosis: a large community-based study, 1994-2006. Gut 2009; 58 (02) 182-188
  • 19 Kamat P, Wen S, Morris J, Anandasabapathy S. Exploring the association between elevated body mass index and Barrett's esophagus: a systematic review and meta-analysis. Ann Thorac Surg 2009; 87 (02) 655-662
  • 20 Cook MB, Shaheen NJ, Anderson LA. et al. Cigarette smoking increases risk of Barrett's esophagus: an analysis of the Barrett's and Esophageal Adenocarcinoma Consortium. Gastroenterology 2012; 142 (04) 744-753
  • 21 Verbeek RE, Spittuler LF, Peute A. et al. Familial clustering of Barrett's esophagus and esophageal adenocarcinoma in a European cohort. Clin Gastroenterol Hepatol 2014; 12 (10) 1656-63.e1
  • 22 Fitzgerald RC, di Pietro M, Ragunath K. et al; British Society of Gastroenterology. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus. Gut 2014; 63 (01) 7-42
  • 23 Shaheen NJ, Falk GW, Iyer PG, Gerson LB. American College of Gastroenterology. ACG clinical guideline: diagnosis and management of Barrett's esophagus. Am J Gastroenterol 2016; 111 (01) 30-50 , quiz 51
  • 24 Triggs JR, Falk GW. Best practices in surveillance for Barrett's esophagus. Gastrointest Endosc Clin N Am 2021; 31 (01) 59-75
  • 25 Gorrepati VS, Sharma P. How should we report endoscopic results in patient's with Barrett's esophagus?. Dig Dis Sci 2018; 63 (08) 2115-2121
  • 26 Amano Y, Ishimura N, Furuta K. et al. Which landmark results in a more consistent diagnosis of Barrett's esophagus, the gastric folds or the palisade vessels?. Gastrointest Endosc 2006; 64 (02) 206-211
  • 27 Sharma P, Dent J, Armstrong D. et al. The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. Gastroenterology 2006; 131 (05) 1392-1399
  • 28 Gross SA, Kingsbery J, Jang J, Lee M, Khan A. Evaluation of dysplasia in Barrett esophagus. Gastroenterol Hepatol (N Y) 2018; 14 (04) 233-239
  • 29 Singh T, Sanghi V, Thota PN. Current management of Barrett esophagus and esophageal adenocarcinoma. Cleve Clin J Med 2019; 86 (11) 724-732
  • 30 Visrodia K, Singh S, Krishnamoorthi R. et al. Magnitude of missed esophageal adenocarcinoma after Barrett's esophagus diagnosis: a systematic review and meta-analysis. Gastroenterology 2016; 150 (03) 599-607.e7 , quiz e14–e15
  • 31 Mannath J, Subramanian V, Hawkey CJ, Ragunath K. Narrow band imaging for characterization of high grade dysplasia and specialized intestinal metaplasia in Barrett's esophagus: a meta-analysis. Endoscopy 2010; 42 (05) 351-359
  • 32 Corley DA, Levin TR, Habel LA, Weiss NS, Buffler PA. Surveillance and survival in Barrett's adenocarcinomas: a population-based study. Gastroenterology 2002; 122 (03) 633-640
  • 33 Qumseya BJ, Wang H, Badie N. et al. Advanced imaging technologies increase detection of dysplasia and neoplasia in patients with Barrett's esophagus: a meta-analysis and systematic review. Clin Gastroenterol Hepatol 2013; 11 (12) 1562-70.e1 , 2
  • 34 Hajelssedig OE, Zorron Cheng Tao Pu L, Thompson JY. et al. Diagnostic accuracy of narrow-band imaging endoscopy with targeted biopsies compared with standard endoscopy with random biopsies in patients with Barrett's esophagus: a systematic review and meta-analysis. J Gastroenterol Hepatol 2021; 36 (10) 2659-2671
  • 35 Sharma P, Brill J, Canto M. et al. White Paper AGA: Advanced Imaging in Barrett's Esophagus. Clinical gastroenterology and hepatology: the Official Clinical Practice Journal of the American Gastroenterological Association. 2015; 13: 2209-2218
  • 36 Daly C, Vennalaganti P, Soudagar S, Hornung B, Sharma P, Gupta N. Randomized controlled trial of self-directed versus in-classroom teaching of narrow-band imaging for diagnosis of Barrett's esophagus-associated neoplasia. Gastrointest Endosc 2016; 83 (01) 101-106
  • 37 Goda K, Fujisaki J, Ishihara R. et al. Newly developed magnifying endoscopic classification of the Japan Esophageal Society to identify superficial Barrett's esophagus-related neoplasms. Esophagus 2018; 15: 153-159
  • 38 Sharma P, Bergman JJ, Goda K. et al. Development and validation of a classification system to identify high-grade dysplasia and esophageal adenocarcinoma in Barrett's esophagus using narrow-band imaging. Gastroenterology 2016; 150 (03) 591-598
  • 39 Furuhashi H, Goda K, Shimizu Y. et al. Feasibility of a simplified narrow-band imaging classification system for Barrett's esophagus for novice endoscopists. J Gastroenterol 2019; 54 (07) 587-596
  • 40 Singh R, Chiam KH, Leiria F, Pu LZCT, Choi KC, Militz M. Chromoendoscopy: role in modern endoscopic imaging. Transl Gastroenterol Hepatol 2020; 5: 39
  • 41 Coletta M, Sami SS, Nachiappan A, Fraquelli M, Casazza G, Ragunath K. Acetic acid chromoendoscopy for the diagnosis of early neoplasia and specialized intestinal metaplasia in Barrett's esophagus: a meta-analysis. Gastrointest Endosc 2016; 83 (01) 57-67.e1
  • 42 Kandiah K, Chedgy FJQ, Subramaniam S. et al. International development and validation of a classification system for the identification of Barrett's neoplasia using acetic acid chromoendoscopy: the Portsmouth acetic acid classification (PREDICT). Gut 2018; 67 (12) 2085-2091
  • 43 Ngamruengphong S, Sharma VK, Das A. Diagnostic yield of methylene blue chromoendoscopy for detecting specialized intestinal metaplasia and dysplasia in Barrett's esophagus: a meta-analysis. Gastrointest Endosc 2009; 69 (06) 1021-1028
  • 44 Canto MI, Anandasabapathy S, Brugge W. et al; Confocal Endomicroscopy for Barrett's Esophagus or Confocal Endomicroscopy for Barrett's Esophagus (CEBE) Trial Group. In vivo endomicroscopy improves detection of Barrett's esophagus-related neoplasia: a multicenter international randomized controlled trial (with video). Gastrointest Endosc 2014; 79 (02) 211-221
  • 45 Trindade AJ, Smith MS, Pleskow DK. The new kid on the block for advanced imaging in Barrett's esophagus: a review of volumetric laser endomicroscopy. Therap Adv Gastroenterol 2016; 9 (03) 408-416
  • 46 Sturm MB, Wang TD. Emerging optical methods for surveillance of Barrett's oesophagus. Gut 2015; 64 (11) 1816-1823
  • 47 Gross SA, Smith MS, Kaul V. US Collaborative WATS3D Study Group. Increased detection of Barrett's esophagus and esophageal dysplasia with adjunctive use of wide-area transepithelial sample with three-dimensional computer-assisted analysis (WATS). United European Gastroenterol J 2018; 6 (04) 529-535
  • 48 Gupta N, Gaddam S, Wani SB, Bansal A, Rastogi A, Sharma P. Longer inspection time is associated with increased detection of high-grade dysplasia and esophageal adenocarcinoma in Barrett's esophagus. Gastrointest Endosc 2012; 76 (03) 531-538
  • 49 Struyvenberg MR, de Groof AJ, van der Putten J. et al. A computer-assisted algorithm for narrow-band imaging-based tissue characterization in Barrett's esophagus. Gastrointest Endosc 2021; 93 (01) 89-98
  • 50 Lui TKL, Tsui VWM, Leung WK. Accuracy of artificial intelligence-assisted detection of upper GI lesions: a systematic review and meta-analysis. Gastrointest Endosc 2020; 92 (04) 821-830.e9
  • 51 Pannala R, Krishnan K, Melson J. et al. Artificial intelligence in gastrointestinal endoscopy. VideoGIE 2020; 5 (12) 598-613